Affimed N.V. Competitors and Similar CompaniesClear all
Affimed N.V.'s competitors and similar companies include BTG.
 Affimed N.V. Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies. | ||
Founding Date | Founding Date 2000 | Founding Date 1948 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Heidelberg, DE HQ | |
Employees | Employees 76 | Employees 650 |
Financial | ||
Revenue (est.) | Revenue (est.) €8.3m (FY, 2023) | Revenue (est.) £731.3m (FY, 2019) |
Cost of goods | Cost of goods N/A | Cost of goods £221m (FY, 2019) |
Gross profit | Gross profit €13m (FY, 2023) | Gross profit £510.3m (FY, 2019) |
Net income | Net income (€105.9m) (FY, 2023) | Net income £88.3m (FY, 2019) |
For sources of this data, please see the company profile